
Insulet Corp
NASDAQ:PODD

During the last 3 months Insulet Corp insiders have not bought any shares, and sold 4m USD worth of shares. The stock price has dropped by 1% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/podd/vs/indx/gspc">open performance analysis).
The last transaction was made on
Mar 25, 2025
by
Frederick Wayne A.i.
(Chief Human Resources Officer)
, who
sold
501.9k USD
worth of PODD shares.
During the last 3 months Insulet Corp insiders have not bought any shares, and sold 4m USD worth of shares. The stock price has dropped by 1% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/podd/vs/indx/gspc">open performance analysis).
The last transaction was made on
Mar 25, 2025
by
Frederick Wayne A.i.
(Chief Human Resources Officer)
, who
sold
501.9k USD
worth of PODD shares.
Insulet Corp
Glance View
Insulet Corporation has carved out a significant niche in the medical device industry, distinguishing itself through its innovative approach to diabetes management. The company is best known for its Omnipod Insulin Management System, a discreet, tubeless insulin pump that provides a solution for individuals with diabetes seeking an alternative to traditional insulin delivery methods. Unlike conventional pumps that require cumbersome tubes and significant patient involvement, the Omnipod system offers ease and convenience, allowing users more freedom and flexibility in their daily lives. The system operates via a small wearable pod that delivers insulin over several days, which users control remotely, removing much of the hassle associated with managing diabetes. Insulet generates revenue by selling these pods and the associated Personal Diabetes Manager (PDM) devices, which together comprise the entire system. Customers typically purchase pods on a recurring basis, similar to a subscription model, which creates a steady stream of revenue for the company. The business model emphasizes continuous growth by expanding its user base and improving its technology to remain at the forefront of patient-centric diabetes care. Insulet's strategic focus on the needs of its users and commitment to refining their health technology has enabled it to build a sustainable business that addresses a critical healthcare challenge while also delivering consistent financial performance.

What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.